ISSN 0974-3618 (Print) www.rjptonline.org
0974-360X (Online)
RESEARCH ARTICLE
Chemical Compounds and Antimicrobial Activities of Actinomycetes Isolates from BRIS Soil
Ali Arkan Majhool1, Hamidah Idris1*, Wan Mohd Nuzul Hakimi2,
Muhd Danish Daniel Abdullah3
1Department of Biology, Faculty of Science and Mathematics, Sultan Idris Education Universiti,
35900 UPSI, Tanjung Malim, Perak, Malaysia.
2Department of Chemistry, Faculty of Science and Mathematics, Sultan Idris Education University,
35900 UPSI, Tanjung Malim, Perak, Malaysia.
3Institute of Marine Biotechnology, Universiti Malaysia Terengganu, 21030 Kuala Nerus,
Terengganu, Malaysia.
*Corresponding Author E-mail: alialjarrahali1986@gmail.com, hamidah.idris@fsmt.upsi.edu.my
ABSTRACT:
The existing study examined three actinomycetes isolated from Beach Ridges Interspersed with Swales (BRIS) soil where the morphological properties were examined and chemical compounds of their metabolite extracts were ana; ysed. Based on phylogenetic analysis of 16S rRNA gene sequences, the strains were identified as Streptomyces sp. AA13, Amycolatopsis sp. AA12 and Micromonosporasp. AA141. Antimicrobial activities of the extracts were tested against a panel of microorganisms that consist of Escherichia coli DSM 30083, Bacillus subtilis DSM 10, Pseudomonas fluorescens DSM 50090, Klebsiella pneumoniae DSM 30104, Micrococcus luteus DSM 20030, and Saccharomyces cerevisiae. Results revealed a wide range of antimicrobial activities produced by the isolates at different concentration of each extracts. The extracts were found to show stronger antimicrobial activities against gram-negative bacteria compared to gram-positive bacteria, while no activities were shown when tested against fungi. Thirty-nine compounds were detected both from Streptomycessp. AA13 and Amycolatopsissp. AA12, while thirty-eight compounds from Micromonosporasp. AA141 using GC-MS. This Study Demonstrate the ability of actinomycetes in producing variety type of compounds with antimicrobial activities that may be the potential candidates as drug leads.
KEYWORDS: Actinomycete, Antimicrobial activity, BRIS soil, GC-MS, Methanol extracts.
INTRODUCTION:
Soil
harbour the life of variety types of microorganisms, including bacteria which
serve as the sources of secondary metabolites producer that act against many
simultaneously existing human pathogenic bacteria and phytopathogenic fungi1.
Among the members of bacteria group, Actinomycetes which are gram-positive
bacteria that play an important part in the production of bioactive materials
of high profitable value2.
Received on 10.08.2020 Modified on 14.09.2020
Accepted on 23.10.2020 © RJPT All right reserved
Research J. Pharm. and Tech. 2021; 14(9):4783-4788.
DOI: 10.52711/0974-360X.2021.00832
Besides, the actinomycete population was determined as one of the main groups of the soil population also they are manufacturers of important antibiotic profiles and possess the capacity to produce a large number of secondary metabolites to support the pharmaceutical industry3. Interestingly, Malaysia is geographically diverse, which support the prosperity of different groups of microorganisms as different species of actinomycetes. Antibiotic-resistant microorganisms remain one of the central reasons for death due to infectious diseases4. This requires the need of extra attention to find solutions towards this problem and one of the alternative is by harnessing rare actinomycetes as novel antibiotic producers. This is due to the fact that actinomycetes carry the potential to produce a broad variety of compounds such as phenols, benzopyranones, alkaloids, flavonoids, benzoquinones, steroids, terpenoids, xanthones, and other natural products5,6. In this project, actinomycetes were isolated from Beach Ridges Interspersed with Swales (BRIS) soil collected from Setiu District, Terengganu, Malaysia subject to testing for antimicrobial activities, secondary metabolite production and compound detection using Gas Chromatography Mass Spectrophotometry (GCMS) approach. Methanol extracts showed unusual properties of antimicrobial activities, secondary metabolites results that indicating to may be rich in novel bioactive compounds.
MATERIAL AND METHODS:
Samples:
BRIS soil samples were obtained from Setiu District, Terengganu, Malaysia, kept in ice and transported to University Pendidikan Sultan Idris immediately.
Isolation of actinomycetes from BRIS soil samples:
1 gram of soil samples was used and serially diluted up to 10−6. Later, 100μl were taken from each dilution and spread on the surface of 2 types of medium (ISP Medium No.2 and Actinomyces agar)7,8 supplemented with nalidixic acid (50μg/mL) and cycloheximide (50 μg/mL)9. Then, the plates were incubated for a month at 30°C. Required colonies were then subcultured onto ISP2 agar and purified using the streak plate method. Glycerol stocks were prepared and plates containing isolated colonies were stored at 4°C to further investigation10.
Colony and cell morphology:
Observation of colony morphology was based on the cultures grown on ISP3 agar11 for 14 days in 30oC. Gram staining and microscopic observation were done to determine cell morphology and Gram type of each isolates.
Phylogenetic analysis:
DNA extraction was done using HiYield Genomic DNA Mini Kit (Real Biotech Corp., Taiwan) followed by 16S rRNA gene amplification using universal primers 27F and 1525 R11. Purified PCR products were sent for sequencing prior to editing using BioEdit version 7.0. Used the Basic Local Alignment Search Tool (BLAST) for the nearest match of each of the edited sequences was established and pairwise sequence similarities well are done by using the 16S-based ID using the EzTaxon-e web server (http://eztaxon-e.ezbiocloud.net)9. Verified and adjusted alignment was used for building a phylogenetic tree based on the neighbor-joining by using the MEGA 7.0 Analysis12.
Metabolite extraction:
Isolates Streptomyces sp. AA13, Amycolatopsis sp. AA12, and MicromonosporaspAA141 were selected for secondary metabolite analysis. The isolates we grown in ISP2 broth7 with shaking for 14 days at 30°C13 followed by centrifugation for 30 minutes at 12,000rpm. Discard the supernatants and transferred the precipitate into new tubes with added methanol and incubated at 37°C with shaking for 3 days to achieve complete extraction. Crude extract of secondary metabolites were prepared by drying the preparations using Rotary Evaporator (rotovap) at 40°C13.
Antimicrobial activity:
Antimicrobial activity of the methanol crude extracts was determined against Bacillus subtilis (DSM 10), Micrococcus luteus (DSM 20030), Klebsiella pneumonia (DSM 30104), Escherichia coli (DSM 30083), Pseudomonas fluorescens (DSM 50090) and Saccharomyces cerevisiae. The microorganisms were grown in Muller-Hinton broth overnight at 37oC prior to testing14.
Agar diffusion method was used to antimicrobial effects of the methanol products15. The microbial lawn was prepared by spreading each microbial suspensions on Muller-Hinton agar. Three dilutions of each crude extracts by methanol were prepared to achieve the concentrations of 125, 250 and 500μg/mL which were then applied on sterile paper discs (6mm diameter). The paper discs were placed on the agar plate. Incubated at 37oC for 24 hours. Antimicrobial activity of each metabolite extracts were determined by measuring the diameter of inhibition zone16.
GC/MS analysis of metabolite extracts:
GC/MS analysis of the crude extracts were conducted using GC-MS (Thermo Electron Corporation, Waltham) provided with HP-5 MS capillary column (30m × 0.25 mm × 0.25μm). The carrier gas was helium with a flow rate of 1mL/min. The column oven temperature was 40 °C at first for 2 minutes then changed it at 10–250 °C/min, which was kept for one minute, and 5–280 °C/min which was kept at 8 minutes. Between m/z 40 and 450 got the electron impact spectra in positive ionization method were acquired17.
RESULTS:
Identification of strains:
All of the isolates were Gram-positive with different colony morphologies as listed in Table 1. Phylogenetic analysis based on 16S rRNA sequences revealed that isolate AA13 belongs to genus Streptomyces and closely related to Streptomyces phaeoluteichromatogenesT. Previous studies reported that genus Streptomyces consist of major potential metabolite producers and carry the potential in producing novel compounds9 Isolate AA12 belongs to genus Amycolatopsis and closely related to Amycolatopsis samaneae RM287T with 98.16% sequence similarity while isolate AA141 belongs to genus Micromonospora and closely related to Micromonospora aurantiaca ATCC 27029T with 99.51% sequence similarity (Figure 1). These 2 genera were reported to produce potential novel compounds with wide range of activities3.
Table 1: Colony morphology of Actinomycete isolates AA12, AA13 and AA141.
Isolate |
Cultural characteristic |
Cell morphology |
Isolate grown on ISP2 agar |
||
Aerial spore mass colour |
Substrate mycelia colour |
Colour of diffusible pigment |
|||
AA12 |
Greenish White |
Pale Greenish yellow |
Light Yellow |
Concave colonies with leathery texture and circular shape, have earthy smell. |
|
AA13 |
Pinkish White |
Light Yellow |
- |
Colonies are powdery, half embedded in solid media, and corkscreww shape. |
|
AA141 |
Strong Orange |
Light Orange Yellow |
_ |
Filamentous bacteria with chalky texture |
|
Fig. 1: Neighbour-joining phylogenetic tree based on 16S rRNA gene sequences showing relationships between isolates AA12, AA13 and AA141 and the type strains of closely related Amycolatopsis, Micromonospora and Streptomyces species
Antimicrobial activities:
Metabolite extracts of three Actinomycetes isolates showed antimicrobial activity against the tested panel of microorganisms as listed in Table 2. Extract from isolate AA12 with 500μg/mL and 250μg/mL concentrations inhibited the growth of four microorganisms which include Escherichia coli DSM 30083T, Pseudomonas fluorescence DSM 50090T, Klebsiellapneumonia DSM 30104T and Micrococcus luteus DSM 20030Twith inhibition zones ranging from 10 to 20cm of diameter. At the concentration of 125μg/mL, isolate AA12 inhibited the growth of Pseudomonas fluorescence DSM 50090T and Klebsiellapneumonia DSM 30104T while isolates AA13 and AA141 showed activity against only Klebsiellapneumonia DSM 30104T. None of the metabolite extract showed activity when tested against Saccharomyces cerevisiae.
Chemical components of metabolite extract:
Extracted metabolites shown different colours between the three isolates that include light orange extract fromisolate AA13, deep yellowish pink extracted from isolateAA12 and the extract of isolateAA141was strong orange in color. Analyses of all extracts were conducted using GC-MS where a total of 39 compounds from isolate.AA13and isolateAA12 and 38 compounds from isolateAA141 were found (Figure 2).
The major compounds detected in metabolite extracts are listed in Table 3. The prevailing compounds of isolateAA13 isolate were detected as Actinomycin C2, Indol, Squalene, Hexadecanamide, Decanamide-, and pyrrolo [1,2-a] pyrazine-1,4-dione and hexahydro- while the main constituent detected from isolate AA12 extract was Pyrrolo [1, 2-a] pyrazine-1, 4-dione, hexahydro- (16.21%). As for isolate AA141, the main constituents of the extract were Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro- (11.69%), Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3 (25.34%), and 2,5-Piperazinedione, 3-benzyl-6-isopropyl- (10.05%), and some bioactive components were also discovered, such as Iodole, Tetradecanoic acid, 12-methyl-, methyl ester, (S), Hexadecanoic acid, methyl ester, and Squalene. Some bioactive components were also discovered, such as Tridecanoic acid from isolate AA141 which is a 13-carbon saturated fatty, showed at retention time 28.333 minutes, this compound shown high level of activity against most of the test organisms18. Actinomycin C2 at retention time 37.027 minutes. This compound exhibited an antimicrobial activity in the study of Shah, (2017) against a number of bacteria19. This compound was also found by Altaee and Hameedin18
Table 2: Inhibition zones (mm) produced by Actinomycetes metabolite extract against a panel of microorganisms
Isolate |
Concentration (μg/mL) |
Tested microorganisms |
|||||
1 |
2 |
3 |
4 |
5 |
6 |
||
AA12 |
500 |
20 |
- |
17 |
14 |
14 |
- |
250 |
10 |
- |
15 |
12 |
10 |
- |
|
125 |
- |
- |
7 |
9 |
- |
- |
|
AA13 |
500 |
12 |
14 |
- |
19 |
- |
- |
250 |
8 |
10 |
- |
14 |
- |
- |
|
125 |
- |
- |
- |
10 |
- |
- |
|
AA141 |
500 |
- |
12 |
13 |
23 |
- |
- |
250 |
- |
8 |
9 |
13 |
- |
- |
|
125 |
- |
- |
- |
9 |
- |
- |
*1: Escherichia coli DSM30083T; 2: Bacillus subtilis DSM10T; 3: Pseudomonas fluorescens DSM50090T; 4: Klebsiella pneumoniae DSM30104T; 5: Micrococcus luteus DSM20030T and 6: Saccharomyces cerevisiae
|
|
|
Fig. 2: GC/MS chromatogram of metabolite extract analysed, with start time: 5 minutes and end time: 56 minutes of isolates (A) AA12, (B) AA13 and (C) AA141
Table 3: Biological activity of the components detected by GC/MS in Actinomycetes metabolite extract.
Name of compounds |
Methanol extract |
R. time |
Biological activity |
Reference |
Indole |
AA13, AA12, and AA141 |
17.3 |
Antimicrobial activity |
[20] |
Hexadecanoic acid, methyl ester |
AA13, AA12, and AA141 |
34.0 |
Antimicrobial activity |
[21] |
Tridecanoic acid |
AA12 |
28.3 |
Anthelminthic, Anti-microbial activities, and anti- cancerous activity |
[18] |
Actinomycin C2 |
AA13 and AA12 |
37.0 |
Antimicrobial activity |
[19] |
Decanamides |
AA12 and AA13 |
37.7 |
Antimicrobial activity |
[22] |
Octacosanol |
AA 12 |
46.2 |
Antimicrobial activity |
[23] |
Squalene |
AA13, AA12, and AA141 |
48.1 |
Antioxidant and antitumor activities |
[24] |
9-Octadecenoic acid, methyl ester |
AA13, AA12, and AA141 |
36.2 |
Antimicrobial activity |
[25] |
γ-butyrolactone |
AA13 |
6.3 |
Antioxidant Activity Analgesic, and Antioedematous |
[26] |
Benzyl Benzoate |
AA13 |
29.4 |
Immunobioloical and insecticidal activities |
[27] |
Methyl stearate |
AA13 and AA141 |
36.7 |
Antioxidant and antimicrobial activities |
[28] |
Diethyl Phthalate |
AA141 |
19.2 |
Antimicrobial activities |
[29] |
Diisooctyl phthalate |
AA141 |
43.8 |
Antibacterial activity |
[30] |
CONCLUSION:
Pandemic COVID-19 has portrayed the importance of effort to be taken in order to find new leads for the development of antibiotics and other drugs. Numbers of research has shown that Actinomycetes carry the potential in producing bioactive compounds3. This Study Significantly in line with previous findings where Actinomycetes were successfully isolated from BRIS soil and found to produce antimicrobial activities. Moreover, their metabolite extracts showed high capacity of antimicrobial activity when tested against a penal of 5 different types of organisms from that consist of Gram positive, Gram negative and yeast samples. GC/MS analysis of the methanol extract detected the presence of variety antimicrobial compounds including Hexadecanoic acid, Indole, Tridecanoic acid, Hexadecanoic acid, methyl ester, Actinomycin C2, Decanamides, 9-Octadecenoic acid, Octacosanol and Squalene. As the conclusion, the diversity and bioactivity of the compounds produced by actinomycetes isolated from BRIS soil offer a great possibility for future applications, mostly in the medical field. Further analysis need to be done in order to find potential producer that can serve as new drug leads.
ACKNOWLEDGMENTS:
This article based on the research project designated Isolation of Soil Actinomycetes and Its Secondary Metabolite for Potential Drugs Against Antibiotic-Resistant Microorganisms. The authors would like to expand their gratitude to Universiti Pendidikan Sultan Idris for the University Research Grants (code: 2018-0142-103-01) that helped the authors for fund the research.
REFERENCES:
1. Jacoby, R., Peukert, M., Succurro, A., Koprivova, A., and Kopriva, S. The role of soil microorganisms in plant mineral nutrition-current knowledge and future directions. Frontiers in Plant Science. 2017; 8; 1617.
2. Subramani, R., and Sipkema, D. Marine rare actinomycetes: a promising source of Structurally Diverse and Unique Novel Natural Products. Marine Drugs. 2019; 17(5): 249.
3. Takahashi, Y., and Nakashima, T. Actinomycetes, an inexhaustible source of Naturally Occurring Antibiotics. Antibiotics. 2018; 7(2): 45.
4. Faja, O., Sharad, A. A., Younis, K. M., Usup, G., and Ahmad, A. Isolation, screening and antibiotic profiling of marine Actinomycetes extracts from the coastal of Peninsular Malaysia. Int. J. Chem Tech Res. 2017; 10: 212-224.
5. Genilloud, O. Actinomycetes: still a source of novel antibiotics. Natural Product Reports. 2017; 34(10): 1203-1232.
6. Wichner, D., Idris, H., Houssen, W. E., McEwan, A. R., Bull, A. T., Asenjo, J. A., ... and Rateb, M. E. Isolation and anti-HIV-1 integrase activity of lentzeosides A–F from extremotolerant lentzea sp. H45, a strain isolated from a high-altitude Atacama Desert soil. The Journal of antibiotics, 2017; 70(4): 448-453.
7. Shirling, E. T., and Gottlieb, D. Methods for characterization of Streptomyces species. International journal of systematic bacteriology. 1966; 16(3): 313-340.
8. Kornman, K. S., and Loesche, W. J. New medium for isolation of Actinomyces viscosus and Actinomyces naeslundii from dental plaque. Journal of clinical microbiology. 1978; 7(6): 514-518.
9. Idris, H., Labeda, D. P., Nouioui, I., Castro, J. F., Del Carmen Montero-Calasanz, M., Bull, A. T and Good fellow, M. S. treptomyces aridus sp. nov., isolated from a high altitude Atacama Desert soil and emended description of Streptomyces noboritoensis Isono et al. 1957. Antonie van Leeuwenhoek, 2017; 110(5): 705-717.
10. Rassem, A. M., David, A. A., and Thomas, T. Phylogenetic analysis of Actinomysetes isolated from rhizospher of Pisum Sativum L. Journal of Pharmacognosy and Phytochemistry. 2018; 7(2): 766-770.
11. Idris, H., Nouioui, I., Pathom-aree, W., Castro, J. F., Bull, A. T., Andrews, B. A. and Goodfellow, M. Amycolatopsis vastitatis sp. nov., an isolate from a high altitude subsurface soil on Cerro Chajnantor, northern Chile. Antonie van Leeuwenhoek, 2018; 111(9): 1523-1533.
12. Idris, H., Nouioui, I., Asenjo, J. A., Bull, A. T., and Goodfellow, M. Lentzea chajnantorensis sp. nov., an actinobacterium from a very high altitude Cerro Chajnantor gravel soil in northern Chile. Antonie Van Leeuwenhoek, 2017; 110(6): 795-802.
13. Rodríguez, C., Álvarez, F., Pérez, L., and Galarza, C. production of antifungal compounds by actinomycetes isolated from Andean and Antarctic soils. Italian Journal of Food Science. 2018; 151-163.
14. Jegan, S., Raj, G. A., Chandrasekaran, M., and Venkatesalu, V. Anti-MRSA Activity of Padina tetrastromatica, Padina gymnospora from Gulf of Mannar Biosphere. World Scientific News. 2019; 115: 15-26.
15. Salleh, W. M. N. H. W., Hashim, N. A., Fabarani, N. P., and Ahmad, F. Antibacterial Activity of Constituents from Piper retrofractum Vahl. And Piper arborescens Roxb. Agriculturae Conspectus Scientificus, 2020; 85(3): 269-280.
16. Salleh, W. M. N. H. W., and Ahmad, F. Phytochemistry and biological activities of the genus Ocotea (Lauraceae): A review on recent research results (2000-2016). Journal of Applied Pharmaceutical Science, 2017; 7(5): 204-218.
17. Lei, W., Peng, Q., Xiu-Feng, L. O. N. G., Zhang, S., Zhi-Gang, Z., and Yong-Qiang, T. Comparative analysis of chemical constituents, antimicrobial and antioxidant activities of ethylacetate extracts of Polygonum cuspidatum and its endophytic actinomycete, Streptomyces sp. A0916. Chinese Journal of Natural Medicines. 2016; 14(2): 117-123.
18. Kavitha, R., and Uduman, M. A. M. Identification of Bioactive Components and Its Biological Activities of Abelmoschas moschatus Flower Extrtact-A Gc-Ms Study. IOSR J. Appl. Chem. 2017; 10: 19-22.
19. Shah, A. M., Hussain, A., Mushtaq, S., Rather, M. A., Shah, A., Ahmad, Z, and Hassan, Q. P. Antimicrobial investigation of selected soil actinomycetes isolated from unexplored regions of Kashmir Himalayas, India. Microbial Pathogenesis. 2017; 110: 93-99.
20. Hodaj, E., Tsiftsoglou, O., Abazi, S., Hadjipavlou-Litina, D., and Lazari, D. Lignans and indole alkaloids from the seeds of Centaurea vlachorum Hartvig (Asteraceae), growing wild in Albania and their biological activity. Natural Product Research. 2017; 31 (10): 1195-1200.
21. Mohammad, H., Prabhu, K., Rao, M. R. K., Sundaram, R. L., Shil, S., and Vijayalakshmi, N. The GC MS studies of one Ayurvedic medicine, Amritarishtam. Research Journal of Pharmacy and Technology. 2019; 12 (1): 351-356.
22. Eberhardt, M. J. Síntese de iodeto de N-(2, 3-dimetil-6-benzotiazolio) decanamida e incorporação em Niossomas Visando Potencial Aplicação Antibacterian. 2017; 21(6): 452-476.
23. Wang, T., Liu, Y. Y., Wang, X., Yang, N., Zhu, H. B., and Zuo, P. P. Protective effects of octacosanol on 6-hydroxydopamine-induced Parkinsonism in rats via regulation of ProNGF and NGF Signaling. Acta Pharmacologica Sinica. 2010; 31(7): 765-774.
24. Huang, Z. R., Lin, Y. K., and Fang, J. Y. Biological and pharmacological activities of squalene and related compounds: Potential Uses in Cosmetic Dermatology. Molecules. 2009; 14 (1): 540-554.
25. Zhang, S., Zu, Y. G., Fu, Y. J., Luo, M., Zhang, D. Y., and Efferth, T. Rapid microwave-assisted transesterification of yellow horn oil to biodiesel using a heteropolyacid solid catalyst. Bioresource Technology. 2010; 101(3): 931-936.
26. Salat, K., Librowski, T., Moniczewski, A., Stanisz-Wallis, K., Wieckowski, K., and Malawska, B. Analgesic, antioedematous and antioxidant activity of γ-butyrolactone derivatives in rodents. Behavioural Pharmacology. 2012; 23(4): 407-416.
27. Diastuti, H., Asnani, A., Rastuti, U., and Anggraeni, M. Toxicity of benzyl benzoate from Kaempferia rotunda L. rhizome. In AIP Conference Proceedings. 2020; 2237(1): 020079. AIP Publishing LLC.
28. Marahatta, A. B., Poudel, B., and Basnyat, R. C. The Phytochemical and Nutritional analysis and biological activity of Tectaria coadunate Linn. International Journal of Herbal Medicine. 2019; 7: 42-50.
29. Oladimeji, O. H., Onu, N. O., and Attih, E. E. Ethyl linalool and diethyl phthalate from Pycnanthus angolensis (Welw.) Warb. African Journal of Pharmacology and Therapeutics. 2017; 6(2).
30. Maroyi, A. The therapeutic potential of Notobubon galbanum: a review of its medicinal uses and phytochemistry. Journal of Pharmaceutical Sciences and Research. 2019; 11(11): 3661-3665